My company Sollievo Pharmaceuticals, Inc.,  has developed a game-changing solution to a growing problem of epidemic proportions that threatens our frontline health care workers.  Violence in the Emergency Department (ED) and psychiatric hospitals is the cause of frequent disability and at times unimaginable life-threatening and career-ending injuries to doctors, nurses, and health care technicians.  The longer a violent patient remains agitated, the greater the risk of harm to both the staff and the patient.  Emergency physicians have expressed that one of the most significant unmet medical needs in the ED is a faster-acting intramuscular sedative. Sollievo's highly differentiated Proviza® fulfills that need. 

While doctors, nurses, and other healthcare workers have expressed excellent support for Sollievo's mission, funding of the endeavor has been frustratingly slow. last fall, after securing an investor he died of COVID prior to funding the investment.  Since that time my personal accounts have been drained while I pursue funding.  The product is ready to move into clinical testing and existing financing efforts appear to be gaining traction.

Your support will allow me to keep myself afloat for the next two months while all efforts are targeted on completing financing for the company.  Please help me to get this much-needed product to the healthcare professionals that are suffering injuries at the hands of agitated patients.